Ledger.Open graph →
SEC Form D · Amendment · filed August 12, 2009

KOLLTAN PHARMACEUTICALS INC

Offering
$40.0M
Sold
$40.0M
Exemption
Industry
Biotechnology
Location
NEW HAVEN, CT
Type

People & firms on this filing (15)

Richard A. Cohen · LONGUEUIL, Quebec, CanadaDirector · PromoterMichael Schmertzler · New Haven, CTExec · DirectorKristor Gervat · New York, NYDirectorArthur G. Altschul, Jr · New York, NYExec · Director · PromoterPeter Hirth · Berkeley, CADirectorJames D. Howard, Jr · Phoenix, AZExecJoseph F. Campagna · Reston, VAExecDavid S. Washburn · Allendale, NJDirector · PromoterJosh Harris · New York, NYDirectorLeigh R. Goehring · Stamford, CTExec · DirectorArthur G. Altschul, Jr · New Haven, CTExec · Director · PromoterW. B. Middlekauff · Lawrenceville, NJExecAxel Bolte · New York, NYDirectorThomas Neff · South San Francisco, CADirectorPeter Hirth · Las Vegas, NVDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗